Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy

Throughout hit-to-lead studies, we have discovered optimized compounds which possess blocking effect toward NF-κB activation and TNFα production in cell as well as inhibition activity against IKKβ.